# Combination of Equisetum Arvense and Palmitoylethanolamide (PEA) for the Management of Patients With Chronic Pain in a Before-after Study

> **NCT07110480** · PHASE1,PHASE2 · COMPLETED · sponsor: **noiVita Srls** · enrollment: 50 (actual)

## Conditions studied

- Chronic Pain
- Chronic Pain (Back / Neck)
- Pain (Visceral, Somatic, or Neuropathic)
- Pain Management

## Interventions

- **DIETARY_SUPPLEMENT:** Supplement

## Key facts

- **NCT ID:** NCT07110480
- **Lead sponsor:** noiVita Srls
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-07-29
- **Primary completion:** 2025-04-30
- **Final completion:** 2025-04-30
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2025-08-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07110480

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07110480, "Combination of Equisetum Arvense and Palmitoylethanolamide (PEA) for the Management of Patients With Chronic Pain in a Before-after Study". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT07110480. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*